{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:24:27Z","timestamp":1790623467898,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to identify novel therapeutic targets for primary open-angle glaucoma (POAG).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The summary-data-based Mendelian randomization (SMR) method was used to evaluate the genetic association between plasma proteins and POAG. Two sets of plasma protein quantitative trait loci (pQTLs) data considered exposures were obtained from the Icelandic Decoding Genetics Study and UK Biobank Pharma Proteomics Project. The summary-level genome-wide association studies data for POAG were extracted from the latest Round 10 release of the FinnGen consortium (8,530 cases and 391,275 controls) and the UK Biobank (4,737 cases and 458,196 controls). Colocalization analysis was used to screen out pQTLs that share the same variant with POAG as drug targets identified. The two-sample Mendelian randomization, reverse causality testing and phenotype scanning were performed to further validate the main findings. Protein-protein interaction, pathway enrichment analysis and druggability assessment were conducted to determine whether the identified plasma proteins have potential as drug targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After systematic analysis, this study identified eight circulating proteins as potential therapeutic targets for POAG. Three causal proteins with strong evidence of colocalization, ROBO1 (OR = 1.38, <jats:italic>p<\/jats:italic> = 1.48 \u00d7 10<jats:sup>\u22124<\/jats:sup>, PPH4 = 0.865), FOXO3 (OR = 0.35, <jats:italic>p<\/jats:italic> = 4.34 \u00d7 10<jats:sup>\u22123<\/jats:sup>, PPH4 = 0.796), ITIH3 (OR = 0.89, <jats:italic>p<\/jats:italic> = 2.76 \u00d7 10<jats:sup>\u22124<\/jats:sup>, PPH4 = 0.767), were considered tier one targets. Five proteins with medium support evidence of colocalization, NCR1 (OR = 1.25, <jats:italic>p<\/jats:italic> = 4.18 \u00d7 10<jats:sup>\u22124<\/jats:sup>, PPH4 = 0.682), NID1 (OR = 1.38, <jats:italic>p<\/jats:italic> = 1.54 \u00d7 10<jats:sup>\u22123<\/jats:sup>, PPH4 = 0.664), TIMP3 (OR = 0.91, <jats:italic>p<\/jats:italic> = 4.01 \u00d7 10<jats:sup>\u22125<\/jats:sup>, PPH4 = 0.659), SERPINF1 (OR = 0.81, <jats:italic>p<\/jats:italic> = 2.77 \u00d7 10<jats:sup>\u22124<\/jats:sup>, PPH4 = 0.59), OXT (OR = 1.17, <jats:italic>p<\/jats:italic> = 9.51 \u00d7 10<jats:sup>\u22124<\/jats:sup>, PPH4 = 0.526), were classified as tier two targets. Additional sensitivity analyses further validated the robustness and directionality of these findings. According to druggability assessment, Pimagedine, Resveratrol, Syringaresinol and Clozapine may potentially be important in the development of new anti-glaucoma agents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our integrated study identified eight potential associated proteins for POAG. These proteins play important roles in neuroprotection, extracellular matrix regulation and oxidative stress. Therefore, they have promising potential as therapeutic targets to combat POAG.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1428472","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T04:46:15Z","timestamp":1723783575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel therapeutic targets for primary open-angle glaucoma identified through multicenter proteome-wide mendelian randomization"],"prefix":"10.3389","volume":"15","author":[{"given":"Weichen","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangkun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1517\/13543784.11.4.565","article-title":"Pimagedine: a novel therapy for diabetic nephropathy","volume":"11","author":"Abdel-Rahman","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0166915","DOI":"10.1371\/journal.pone.0166915","article-title":"Oxidative and anti-oxidative stress markers in chronic glaucoma: a systematic review and meta-analysis","volume":"11","author":"Benoist d'Azy","year":"2016","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00109-022-02281-5","article-title":"FoxO3 and oxidative stress: a multifaceted role in cellular adaptation","volume":"101","author":"Bernardo","year":"2023","journal-title":"J. Mol. Med. Berl."},{"key":"B4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fimmu.2019.00381","article-title":"Autoantibody biomarker discovery in primary open angle glaucoma using serological proteome analysis (SERPA)","volume":"10","author":"Beutgen","year":"2019","journal-title":"Front. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1432-1327.1998.2520339.x","article-title":"Inter-alpha-trypsin inhibitor proteoglycan family--a group of proteins binding and stabilizing the extracellular matrix","volume":"252","author":"Bost","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/02713680490904377","article-title":"Clozapine directly relaxes bovine retinal arteries","volume":"30","author":"Boussery","year":"2005","journal-title":"Curr. Eye Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3390\/nu14142974","article-title":"The role of Resveratrol in eye diseases-A review of the literature","volume":"14","author":"Bryl","year":"2022","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1124\/pr.120.019398","article-title":"Is oxytocin \"nature's medicine","volume":"72","author":"Carter","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"141905","DOI":"10.1155\/2015\/141905","article-title":"Systemic and ocular hemodynamic risk factors in glaucoma","volume":"2015","author":"Choi","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2337\/diab.41.4.552","article-title":"Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction","volume":"41","author":"Corbett","year":"1992","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/014107680710000923","article-title":"Capitalizing on Mendelian randomization to assess the effects of treatments","volume":"100","author":"Davey Smith","year":"2007","journal-title":"J. R. Soc. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.ophtha.2005.04.018","article-title":"Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study","volume":"112","author":"de Voogd","year":"2005","journal-title":"Ophthalmology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1167\/iovs.17-23223","article-title":"FOXC1 regulates expression of prostaglandin receptors leading to an attenuated response to latanoprost","volume":"59","author":"Doucette","year":"2018","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1255889","DOI":"10.3389\/fendo.2023.1255889","article-title":"Using proteomics and metabolomics to identify therapeutic targets for senescence mediated cancer: genetic complementarity method","volume":"14","author":"Fang","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3324\/haematol.2013.090076","article-title":"Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice","volume":"99","author":"Franco","year":"2014","journal-title":"Haematologica"},{"key":"B17","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1167\/iovs.09-3779","article-title":"Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy","volume":"51","author":"Huang","year":"2010","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1442-9071.2002.00480.x","article-title":"Relationship between the concentration of copper and iron in the aqueous humour and intraocular pressure in rabbits treated with topical steroids","volume":"30","author":"Iqbal","year":"2002","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2007.02.001","article-title":"Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism","volume":"417","author":"Jacob","year":"2007","journal-title":"Neurosci. Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.26355\/eurrev_201907_18287","article-title":"Correlations of TIMP2 and TIMP3 gene polymorphisms with primary open-angle glaucoma","volume":"23","author":"Ji","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1167\/iovs.16-20336","article-title":"Myocilin regulates metalloprotease 2 activity through interaction with TIMP3","volume":"58","author":"Joe","year":"2017","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e25775","DOI":"10.1371\/journal.pone.0025775","article-title":"Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology","volume":"6","author":"Jun","year":"2011","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ceo.14027","article-title":"Pathogenesis of glaucoma: extracellular matrix dysfunction in the trabecular meshwork-A review","volume":"50","author":"Keller","year":"2022","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.3390\/ijms23073709","article-title":"ELK3 controls gastric cancer cell migration and invasion by regulating ECM remodeling-related genes","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2200771","DOI":"10.1002\/mnfr.202200771","article-title":"Syringaresinol alleviates early diabetic retinopathy by downregulating HIF-1\u03b1\/VEGF via activating Nrf2 antioxidant pathway","volume":"68","author":"Liu","year":"2024","journal-title":"Mol. Nutr. Food Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/s1357-2725(01)00078-4","article-title":"NKp46","volume":"33","author":"Mandelboim","year":"2001","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"378641","DOI":"10.5402\/2012\/378641","article-title":"Distribution of nidogen in the murine eye and ocular phenotype of the nidogen-1 knockout mouse","volume":"2012","author":"May","year":"2012","journal-title":"ISRN Ophthalmol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1167\/iovs.08-3061","article-title":"Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress","volume":"50","author":"Miyamoto","year":"2009","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9944","DOI":"10.1073\/pnas.96.17.9944","article-title":"Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma","volume":"96","author":"Neufeld","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2202-8-11","article-title":"Pigment epithelium-derived factor protects retinal ganglion cells","volume":"8","author":"Pang","year":"2007","journal-title":"BMC Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.mcn.2007.12.017","article-title":"Robos are required for the correct targeting of retinal ganglion cell axons in the visual pathway of the brain","volume":"37","author":"Plachez","year":"2008","journal-title":"Mol. Cell Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.3849","article-title":"Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization","volume":"21","author":"Rama","year":"2015","journal-title":"Nat. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/ph16060870","article-title":"Elevated intraocular pressure and glaucomatous optic neuropathy: genes to disease mechanisms, therapeutic drugs, and gene therapies","volume":"16","author":"Sharif","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1167\/iovs.17-23434","article-title":"Proteomic alterations in aqueous humor from patients with primary open angle glaucoma","volume":"59","author":"Sharma","year":"2018","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0301-0082(00)00057-5","article-title":"Zinc in the retina","volume":"64","author":"Ugarte","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"D1074-D1082","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/archopht.116.12.1640","article-title":"Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study","volume":"116","author":"Wolfs","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","article-title":"Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits","volume":"9","author":"Wu","year":"2018","journal-title":"Nat. Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1038\/s41598-020-62189-3","article-title":"Integrative analyses indicate an association between ITIH3 polymorphisms with autism spectrum disorder","volume":"10","author":"Xie","year":"2020","journal-title":"Sci. Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1196\/annals.1395.020","article-title":"Pseudoexfoliation syndrome and trace elements","volume":"1100","author":"Yildirim","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"107795","DOI":"10.1016\/j.exer.2019.107795","article-title":"Update on the genetics of primary open-angle glaucoma","volume":"188","author":"Youngblood","year":"2019","journal-title":"Exp. Eye Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12967-024-04919-z","article-title":"Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1428472\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T04:46:18Z","timestamp":1723783578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1428472\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":52,"alternative-id":["10.3389\/fphar.2024.1428472"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1428472","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"article-number":"1428472"}}